Skip to main content
SI
NYSE Industrial Applications And Services

Shoulder Innovations Tops Q3 Revenue Estimates, Lifts 2026 Outlook to $68M-$70M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.37
Mkt Cap
$424.082M
52W Low
$10.92
52W High
$24.595
52W Position info
87% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

SI sits 87% above its 52-week low of $10.92.

Summary

Shoulder Innovations grew Q3 revenue 38% to $16.2M at a 78.5% gross margin and raised full-year 2026 guidance to $68M-$70M, while disclosing a settlement of all patent litigation with Catalyst OrthoScience.


Key Events · Earnings and Guidance · SI

  • Q3 Revenue Up 38% to $16.2M

    Net revenue climbed to $16.2 million from $11.8 million a year earlier, powered by 2,126 implant systems sold (up ~34%) and a 2% higher average selling price of $7,616.

  • Full-Year Guidance Raised

    The 2026 net revenue outlook was lifted to $68 million-$70 million (44%-48% growth) from the prior $67 million-$69 million (42%-46%).

  • Patent Litigation Settled

    A settlement agreement with Catalyst OrthoScience Inc. resolves all outstanding patent litigation between the two companies.

  • Losses Narrow, Cash Cushion Solid

    Net loss came in at $7.0 million ($0.34/share) versus $8.7 million a year ago; adjusted EBITDA loss improved to $5.5 million from $7.5 million, and cash plus marketable securities totaled $92.3 million at September 30, 2026.


Analysis · SI · Industrial Applications And Services

The quarter delivered 38% revenue growth to $16.2M, with gross margin expanding to 78.5%, and management raised full-year guidance to $68M-$70M (44%-48% growth) from $67M-$69M. Equally important, a settlement with Catalyst OrthoScience ends all outstanding patent litigation, clearing a legal overhang. Losses remain—a $7.0M net loss and a $5.5M adjusted EBITDA loss—but $92.3M in cash and securities should fund the InSet Neo robotic platform without near-term financing pressure.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SI was trading at $20.37 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $424.1M. The 52-week trading range was $10.92 to $24.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SI - Latest Insights

SI
Nov 05, 2026, 5:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.37
Real-time Price: $20.15 info
Change: -$0.220 (-1%) info
Market Cap: $421.59M info
SI
Nov 05, 2026, 4:11 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.37
Real-time Price: $20.15 info
Change: -$0.220 (-1%) info
Market Cap: $421.59M info
SI
Sep 10, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $19.48
Real-time Price: $20.15 info
Change: +$0.670 (+3%) info
Market Cap: $421.59M info
SI
Aug 07, 2026, 4:09 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $20.59
Real-time Price: $20.15 info
Change: -$0.440 (-2%) info
Market Cap: $421.59M info
SI
Aug 06, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.43
Real-time Price: $20.15 info
Change: -$2.28 (-10%) info
Market Cap: $421.59M info